Eiger BioPharmaceuticals Inc (EIGRQ)

[rgqui2000]

Marilynt,

Based on information we have at present, on a pro forma basis for the combined company, current Celladon shareholders are expected to own approximately 22%, current Eiger shareholders approximately 45% and the new Eiger investor syndicate approximately 33%, each on a fully-diluted basis.

An investor syndicate has committed to invest $39.5 million in the combined company --- Six million dollars of the financing has already been funded, and the remaining $33.5 million is expected to close contemporaneously with the completion of the proposed merger.

Therefore, $39.5MM / 33% = $119MM is the valuation for the new company. Based on the 22% share, the investors valued the current CLDN at $26MM which is quite low vs. its current market cap of $37MM.

Your thoughts?